Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + DMARDs/biologic
HAQ improvement of >0.3 or MHAQ decrease of >0.22 (changes exceeding MCID) · patients with rheumatoid arthritis
Tocilizumab 8 mg/kg + MTX/DMARD leads to higher HAQ improvement of >0.3 or MHAQ decrease of >0.22 (changes exceeding… compared with placebo + MTX/DMARD (high certainty).
1 finding from 1 review
- RR 1.79 [1.62, 1.94]1 study · 1220 participantsHigh